Market Risks Facing Antimicrobial Technology Firms
Antimicrobial technology firms in the United States operate at the intersection of urgent public health need and complex market realities. While antimicrobial resistance continues to be recognized as a growing global threat, commercial incentives for developing new antimicrobial solutions remain constrained. This imbalance is shaping a challenging risk landscape for companies focused on antibiotics, antifungals, … Read more